COLL — Collegium Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.14bn
- $1.50bn
- $566.77m
- 85
- 67
- 96
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -22.7 | 26.8 | 71.5 | -25 | 48.2 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 16.8 | 30.9 | 27.7 | 36.2 | 57.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 18.2 | -25.3 | 13.5 | -12.7 | 21.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 27.8 | 93.9 | 104 | 124 | 275 |
Capital Expenditures | -6.44 | -374 | -1.94 | -574 | -0.461 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | -70.4 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -6.44 | -374 | -1.94 | -574 | -70.8 |
Financing Cash Flow Items | -0.822 | -2.25 | -4.15 | -4.04 | -8.36 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.04 | 286 | -89.3 | 437 | -140 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 23.4 | 6.64 | 12.3 | -12.7 | 63.8 |